StockData
enGene Therapeutics Inc. logo

enGene Therapeutics Inc. (ENGN) stock

ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30
$1.85+0.13 (+7.56%)

Close on Nov 18, 2026Market cap $123.98MP/E –Yield 0.00%

enGene Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for enGene Therapeutics

enGene Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More enGene Therapeutics figures

See a number that looks wrong?